We have identified several issues that can be the origin of a highly priced medicine. Please find an overview of all issues below.
Access problems due to monopoly |
* Patent or IP legislation |
* Supplementary protection certificates |
* Data exclusivity |
* Orphan market exclusivity |
* Only one product registered |
* No generic or therapeutic competition |
* Supply chain issues |
* API monopoly |
Access problems due to high prices |
* High prices due to monopoly |
* High prices not due to monoply |
* High production costs |
* High ingredient costs |
Access problems due to other barriers |
* Weak health system |
* Weak distribution system |
* Registration barriers |
* Financing or insurance barriers |